💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

UPDATE 1-EU gives conditional approval to BASF buy of Cognis

Published 11/30/2010, 02:03 PM
Updated 11/30/2010, 02:08 PM

* EU OK conditional on sale of hydroxy monomers business

* BASF- sales were below 100 million eur in that business

* BASF- China regulator also approved Cognis acquisition

* BASF sees deal closing in first half of December

(Adds BASF comment)

BRUSSELS, Nov 30 (Reuters) - German chemical industry leader BASF won conditional European Union regulatory approval on Tuesday for its 3.1 billion euro ($4 billion) purchase of smaller peer Cognis to reinforce its presence in the cosmetic additives market.

The European Commission said the condition of the merger was BASF's divestment of its activities in the hydroxy monomers, a chemical product used in coatings and adhesives.

"The approval is subject to the divestiture of businesses that accounted for sales of significantly less than 100 million euros, which is less than 3 percent of Cognis' total sales," BASF said.

Chinese regulators have also approved the acquisition, BASF said, adding that it expected the transaction to close in the first half of December.

BASF unveiled the deal in June, forecasting a boost in earnings per share from 2012 from the acquisition. The takeover will add products such as additives for cleaning products and chemicals derived from palm, coconut and corn.

"The proposed transaction, as initially notified, would have created a very strong player in a market where concentration is already high," the Commission said in a statement.

"To remedy the Commission's concerns, BASF offered to divest activities in the sector in question."

BASF's core chemicals and plastics business is heavily dependant on industries such as autos and construction, both of which were hit hard by the economic crisis. It expects to close the Cognis deal in November.

(Additional reporting by Jonathan Gould in Frankfurt; Editing by Erica Billingham)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.